Seminars in Diagnostic Pathology
Volume 24, Issue 4 , Pages 227-236 , November 2007

The pathology of dengue hemorrhagic fever

  • Anthony S.-Y. Leong, MBBS, MD, FRCPA, FRCPath, FCAP, FASCP, FHKAMed (Pathol), Hon FHKCPath, Hon FRCPT

      Affiliations

    • Hunter Area Pathology Service and University of Newcastle, Newcastle, Australia
    • Corresponding Author InformationAddress reprint requests and correspondence: Anthony S-Y Leong, MD, Hunter Area Pathology Service, Locked Bag 1, HRMC, Newcastle, NSW 2310, Australia.
    • ,
  • K. Thong Wong, MBBS, FRCPath

      Affiliations

    • Department of Pathology, University of Malaya, Selangor, Malaysia
    • ,
  • Trishe Y.-M. Leong, MBBS (hons), FRCPA, FCAP

      Affiliations

    • Victoria Cytology Service, Melbourne, Australia
    • ,
  • Puay Hoon Tan, MBBS, FAMS, MD, FRCPath, FRCPA

      Affiliations

    • Department of Pathology, Singapore General Hospital, Singapore
    • ,
  • Pongsak Wannakrairot, MD, FRCPT

      Affiliations

    • Department of Pathology, Chulalongkorn University, Bangkok, Thailand.

References 

  1. Gubler DJ. Dengue/dengue hemorrhagic fever: history and current status. Novartis Found Symp. 2006;277:3–16
  2. Gubler DJ. Dengue and dengue hemorrhagic fever. Clin Microbiol Rev. 1998;11:480–496
  3. Gibbons RV, Vaughn DW. Dengue: an escalating problem. Br Med J. 2002;324:1563–1566
  4. Burke DS, Monath TP. Flaviviruses. In:  Knipe DM,  Howley PM editor. ed 4. Fields Virology. vol 1:Philadelphia, PA: Williams and Wilkins; 2001;p. 1043–1126
  5. Chaturvedi UC, Nagar R, Shrivastava R. Dengue and dengue hemorrhagic fever: implications of host genetics. FEMS Immunol Med Microbiol. 2005;47:155–166
  6. Fink J, Gu F, Vasudevan SG. Role of T cells, cytokines and antibody in dengue fever and dengue hemorrhagic fever. Rev Med Virol. 2006;16:263–275
  7. Halstead SB. Neutralization and antibody-dependent enhancement of dengue viruses. Adv Virus Res. 2003;60:421–467
  8. Fernando RL, Fernando SSE, Leong AS-Y. Tropical Infectious Diseases. In: London: Greenwich Medical Media; 2001;p. 279–280
  9. World Health Organisation. Dengue Hemorrhagic Fever: Diagnosis, Treatment, Prevention and Control. (ed 2). Geneva: World Health Organisation; 1997;
  10. Wilder-Smith A, Schwartz E. Dengue in travellers. N Engl J Med. 2005;353:924–932
  11. Nugyen TL, Nguyen TH, Tien NT. The impact of dengue hemorrhagic fever on liver function. Res Virol. 1997;148:273–277
  12. Balmeseda A, Hammond SN, Perez MA, et al. Short report: assessment of the World Health Organisation scheme for classification of dengue severity in Nicaragua. Am J Trop Med Hyg. 2006;73:1059–1062
  13. Kamath SR, Ranjit S. Clinical features, complications and atypical manifestations of children with severe forms of dengue hamorrhagic fever in South India. Indian J Pediatr. 2006;73:889–895
  14. Boonpucknavig V, Soontornniyomkij V. Pathology of renal diseases in the tropics. Semin Nephrol. 2003;23:88–106
  15. Seet RCS, Quek AML, Lim ECH. Post-infectious fatigue syndrome in dengue infection. J Clin Virol. 2007;38:1–6
  16. Kumar J, Kumar A, Gupta S, et al. Dengue hemorrhagic fever: an unusual cause of intracranial hemorhage. J Neurol Neurosurg Psychiatry. 2007;78:253
  17. Ling LM, Wilder-Smith A, Leo YS. Fulminant hepatitis in dengue hemorrhagic fever. J Clin Virol. 2007;38:265–268
  18. Khor BS, Liu JW, Lee IK, et al. Dengue hemorrhagic fever patients with acute abdomen: clinical experience of 14 cases. Am J Trop Med Hyg. 2006;74:901–904
  19. Lu PL, Hsiao HH, Tsai JJ, et al. Dengue virus-associated hemophagocytic syndrome and dyserythropoiesis: a case report. Kaohsiung J Med Sci. 2005;21:34–39
  20. Wiwanitkit V. Dengue myocarditis, rare but not fatal manifestation. Int J Cardiol. 2006;10:122
  21. Pokidysheva E, Zhang Y, Battisti AJ, et al. Cryo-EM reconstruction of dengue virus in complex with the carbohydrate recognition domain of DC-SIGN. Cell. 2006;124:485–493
  22. Pulendren B, Ahmed R. Translating innate immunity into immunological memory: implications for vaccine development. Cell. 2006;124:849–863
  23. Cardosa MJ, Porterfield JS, Gordon S. Complement receptor mediates enhanced Flavivirus replication in macrophages. J Exp Med. 1983;158:258–263
  24. Gollins SW, Porterfield JS. A new mechanism for the neutralisation of enveloped viruses by anti-viral antibody. Nature. 1986;321:421–467
  25. Palmer DR, Sun P, Celluzzi C, et al. Differential effects of dengue virus on infected and bystander dendritic cells. J Virol. 2005;79:2432–2439
  26. Chang TH, Liao CL, Lin YL. Flavivirus induces interferon-beta gene expression through a pathway involving RIG-I-independent IRF-3 and PI3K-dependent NF-kappaB activation. Microbes Infect. 2006;8:157–171
  27. Green S, Rothman A. Immunopatholgical mechanisms in dengue and dengue hemorrhagic fever. Curr Opin Infect Dis. 2006;19:429–436
  28. Navarro-Sanchez E, Despres P, Cedillo-Barron L. Innate immune responses to dengue virus. Arch Med Res. 2005;36:425–435
  29. Shresta S, Kyle JL, Beatty PR, et al. Early activation of natural killer and B cells in response to primary dengue virus infection in A/J mice. Virology. 2004;319:262–273
  30. Bente DA, Melkus MW, Garcia JV, et al. Dengue fever in humanised NOD/SCID mice. J Virol. 2005;79:13797–13799
  31. Littaua R, Kurane I, Ennis FA. Human IgG Fc receptor II mediates antibody-dependent enhancement of dengue virus infection. J Immunol. 1990;144:3183–3186
  32. Jessie K, Fong MY, Devi S, et al. Localisation of dengue virus in naturally infected human tissues, by immunohistochemistry and in situ hybridisation. J Infect Dis. 2004;189:1411–1418
  33. Huang KJ, Yang YC, Lin YS, et al. The dual-specific binding of dengue virus and target cells for the antibody-dependent enhancement of dengue virus infection. J Immunol. 2006;176:2825–2832
  34. Vaughn DW, Green S, Kalayanarooj S, et al. Dengue viremia titre, antibody response pattern, and virus serotype correlate with disease severity. J Infect Dis. 2000;181:2–9
  35. Libraty DH, Endy TP, Houng HS, et al. Differing influences of virus burden and immune activiation on disease severity in secondary dengue-3 virus infections. J Infect Dis. 2002;185:1213–1221
  36. Kliks SC, Nisalak A, Brandt WE, et al. Antibody-dependent enhancement of dengue virus growth in human monocytes as a risk factor for dengue hemorrhagic fever. Am J Trop Med Hyg. 1989;40:444–451
  37. Laoprasopwattana K, Libraty DH, Endy TP, et al. Dengue virus (DV) enhancing antibody activity in pre-illness plasma does not predict subsequent disease severity or viremia in secondary DV infection. J Infect Dis. 2005;192:510–519
  38. Kliks SC, Nimmanitya S, Nisalak A, et al. Evidence that maternal dengue antibodies are important in the development of dengue hemorrhagic fever in infants. Am J Trop Med Hyg. 1988;38:411–419
  39. Libraty DH, Young PR, Pickering D, et al. High circulating levels of the dengue virus non-structural protein NS1 early in dengue illness correlate with the development of dengue hemorrhagic fever. J Infect Dis. 2002;186:1165–1168
  40. Chung KM, Nybakken GE, Thompson BS, et al. Antibodies against West Nile virus non-structural protein NS1 prevent lethal infection through Fc gamma receptor-dependent and independent mechanisms. J Virol. 2006;80:1340–1351
  41. Costa SM, Paes MV, Barreto DF, et al. Protection against dengue type 2 virus induced in mice immunized with a DNA plasmid encoding the non-structural 1 (NS1) gene fused to the tissue plasminogen activator signal sequence. Vaccine. 2006;24:195–205
  42. Lin CF, Lei HY, Shiau AL, et al. Antibodies from dengue patient sera cross-reacts with endothelial cells and induces damage. J Med Virol. 2003;69:82–90
  43. Lin CF, Chiu SC, Hsiao YL, et al. Expression of cytokine, chemokine, and adhesion molecules during endothelial activation induced by antibodies against dengue virus non-structural protein 1. J Immunol. 2005;174:395–403
  44. Alvarez M, Rodrigue-Roche R, Bernardo I, et al. Dengue hemorrhagic fever caused by sequential dengue 1-3 infections at a long interval: Havana epidemic. Am J Trop Med Hyg. 2006;75:1113–1117
  45. Endy TP, Nisalak A, Chunsuttiwat S, et al. Spatial and temporal circulation of dengue virus serotypes: a prospective study of primary school children in Kamphaeng Phet, Thailand. Am J Epidemiol. 2002;56:52–59
  46. Endy TP, Nisalak A, Chunsuttitwat S, et al. Relationship of pre-existing dengue virus (DV) neutralizing antibody levels to viremia and severity of disease in a prospective cohort study of DV infection in Thailand. J Infect Dis. 2004;189:990–1000
  47. Mongkolsapaya J, Dejnirattisai W, Xu XN, et al. Original antigenic sin and apoptosis in the pathogenesis of dengue hemorrhagic fever. Nat Med. 2003;921–927
  48. Mongkolsapaya J, Duangchinda T, Dejnirattisai W, et al. T cell responses in dengue hemorrhagic fever: are cross-reactive T cells suboptimal?. J Immunol. 2006;176:3821–3829
  49. Mangada MM, Rothman AL. Altered cytokine responses of dengue-specific CD4+ T cells to heterologous serotypes. J Immunol. 2005;175:2676–2683
  50. Bashyam HS, Green S, Rothman AL. Dengue virus-reactive CD8+ T cell display quantitative and qualitative differences in their response to variant epitopes of heterologous viral serotypes. J Immunol. 2006;176:2817–2824
  51. Page KR, Scott AL, Manabe YC. The expanding realm of heterologous immunity: friend or foe?. Cell Microbiol. 2006;8:185–196
  52. Mathew A, Kurane I, Green S, et al. Impaired T cell proliferation in acute dengue infection. J Immunol. 1999;162:5609–5615
  53. Pichyangkul S, Endy TP, Kalayanarooj S, et al. A blunted blood plasmacytoid dendritic cell response to an acute systemic viral infection is associated with increased disease severity. J Immunol. 2003;171:5571–5578
  54. Simmons CP, Dong T, Chau NV, et al. Early T cell responses to dengue virus epitopes ion Vietnamese adults with secondary dengue virus infections. J Virol. 2005;79:5665–5675
  55. Talavera D, Castillo AM, Dominguez MD, et al. IL8 release, tight junction and cytoskeleton dynamic reorganisation conducive to permeability increase are induced by dengue virus infection of microvascular endothelial monolayers. J Gen Virol. 2004;85:1801–1813
  56. Dewi BE, Takasaki T, Kurane I. In vitro assessment of human endothelial cell permeability: effects of inflammatory cytokines and dengue virus infection. J Virol Methods. 2004;121:171–180
  57. Avirutnan P, Punyadee N, Noisakran S, et al. Vascular leakage in severe dengue virus infections: a potential role for the non-structural viral protein NS1 and complement. J Infect Dis. 2006;193:1078–1088
  58. Cardier JE, Marinao E, Romano E, et al. Proinflammatory factors present in sera from patients with acute dengue infection induce activation and apoptosis of human microvascular endothelial cells: possible role of TNF-α in endothelial cell damage in dengue. Cytokine. 2005;30:359–365
  59. Shresta S, Sharar KL, Prigozhin DM, et al. Murine model for dengue virus-induced lethal disease with increased vascular permeability. J Virol. 2006;80:10208–10217
  60. Boonpucknavig S, Boonpucknavig V, Bhamarapravati N, et al. Immunofluorescence study of skin rash in patients with dengue hemorrhagic fever. Arch Pathol Lab Med. 1979;103:463–466
  61. Perez AB, Garcia G, Sierra B, et al. IL-10m levels in dengue patients: some findings from the exceptional epidemiological conditions in Cuba. J Med Virol. 2004;73:230–234
  62. Nguyen TH, Nguyen TL, Lei HY, et al. Association between sex, nutritional status, severity of dengue hemorrhagic fever, and immune status in infants with dengue hemorrhagic fever. Am J Trop Med Hyg. 2005;72:370–374
  63. Chakravarti A, Kumaria R. Circulating levels of tumor necrosis factor-alpha and interferon-gamma in patients with dengue and dengue hemorrhagic fever during an outbreak. Indian J Med Res. 2006;123:25–30
  64. Huang YH, Lei HY, Liu CC, et al. Tissue plasminogen activator induced by dengue virus infection of human endothelial cells. J Med Virol. 2003;70:610–616
  65. Chen LC, Lei HY, Liu CC, et al. Correlation of serum levels of macrophage migration inhibitory factor with disease severity and clinical outcome in dengue patients. Am J Trop Med Hyg. 2006;74:142–147
  66. Wang S, He R, Patarapotikul J, et al. Antibody-enhanced binding of dengue-2 virus to human platelets. Virology. 1995;213:254–257
  67. Lin CF, Lei HY, Liu CC, et al. Generation of IgM anti-platelet autoantibody in dengue patients. J Med Virol. 2001;63:143–149
  68. Medin CL, Fitzgerald KA, Rothman AL. Dengue virus non-structural protein/NS5 induces interleukin-8 transcription and secretion. J Virol. 2005;79:11053–11061
  69. Pang T, Cardosa MJ, Guzman MG. Of cascades and perfect storms: the immunopathogenesis of dengue hemorrhagic fever-dengue shock syndrome (DHF/DSS). Immunol Cell Biol. 2007;85:43–45
  70. Barreto DF, Takiya CM, Paes MV, et al. Histopathological aspects of Dengue-2 virus infected mice tissues and complementary virus isolation. J Submicrosc Cytol Pathol. 2004;36:121–130
  71. Huerre MR, Lan NT, Marianneau P, et al. Liver histopathology and biological correlates in five cases of fatal dengue fever in Vietnamese children. Virchows Arch. 2001;438:107–115
  72. Carvalho de Macedo F, Nicol AF, Cooper LD, et al. Histologic, viral, and molecular correlates of dengue fever infection of the liver using highly sensitive immunohistochemistry. Diagn Mol Pathol. 2006;15:223–228
  73. Sahaphong S, Riengrojpitak S, Bhamarapravati N, et al. Electron microscopic study of the vascular endothelial cell in dengue hemorrhagic fever. Southeast Asian J Trop Med Pub Health. 1980;11:194–204
  74. de la C Sierra B, Kouri G, Guzman MG. Race: a risk factor for dengue hemorrhagic fever. Arch Virol. 2007;152:533–542
  75. Gubler DJ. The global pandemic of dengue/dengue hemorrhagic fever: current status and prospects for the future. Ann Acad Med Singapore. 1998;27:227–234
  76. Halstead SB, Streit TG, Lfontant JG, et al. Haiti: absence of dengue hemorrhagic fever despite hyperendemic dengue virus transmission. Am J Med Hyg. 2001;65:180–183
  77. Loke H, Bethell DB, Phung CX, et al. Strong HLA class-I restricted T cell responses ind engue hemorrhagic fever (A double-edged sword?). J Infect Dis. 2001;184:1369–1373
  78. LaFluer C, Granados J, Vargas-Alarcon G, et al. HLA-DR antigen frequencies in Mexican patients with dengue virus infections: HLA-DR4 as a possible genetic resistance factor for dengue hemorrhagic fever. Hum Immunol. 2002;63:1039–1044

PII: S0740-2570(07)00093-7

doi: 10.1053/j.semdp.2007.07.002

Seminars in Diagnostic Pathology
Volume 24, Issue 4 , Pages 227-236 , November 2007

Article Tools

* Image Usage & Resolution